These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31513542)

  • 1. The Current Landscape of Veterinary Compounding in the Pharmacy Setting.
    Gochenauer AE; Holmes ER; Barber KE; Forsythe LR
    Int J Pharm Compd; 2019; 23(5):422-427. PubMed ID: 31513542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Current Landscape of Veterinary Compounding in the Veterinary Setting.
    Gochenauer AE; Rishniw M; Holmes ER; Forsythe LR
    Int J Pharm Compd; 2019; 23(5):428-433. PubMed ID: 31513543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
    Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
    Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
    Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
    Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounding for animal patients: contemporary issues.
    Lust E
    J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compounding practices and beliefs of Arizona pharmacists.
    Cauthon KA; Bowman BJ; Gurney MK
    Int J Pharm Compd; 2013; 17(2):154-61. PubMed ID: 23696176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extemporaneous compounding in veterinary practice: a New Zealand perspective.
    Gargiulo DA; Chemal C; Joda L; Lee YJ; Pilkington M; Haywood A; Garg S
    N Z Vet J; 2013 Nov; 61(6):311-5. PubMed ID: 23544952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing pet owner and veterinarian perceptions of need for veterinary compounding services in a community pharmacy setting.
    Bennett SA; Ruisinger JF; Prohaska ES; Steele KM; Melton BL
    Pharm Pract (Granada); 2018; 16(3):1224. PubMed ID: 30416625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States.
    Lobb WB; Wilkin NE; Holmes ER
    Int J Pharm Compd; 2015; 19(6):514-20. PubMed ID: 26891565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent community pharmacists' perspectives on compounding in contemporary pharmacy education.
    Martin KS; McPherson TB; Fontane PE; Berry T; Chereson R; Bilger R
    Am J Pharm Educ; 2009 May; 73(3):54. PubMed ID: 19564997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in compounding of oral liquids for pediatric patients: a patient safety concern.
    Rood JM; Engels MJ; Ciarkowski SL; Wagenknecht LD; Dickinson CJ; Stevenson JG
    J Am Pharm Assoc (2003); 2014; 54(4):383-9. PubMed ID: 25063260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical Compounding in Portuguese Community Pharmacies: CHARACTERIZATION AND FUTURE PERSPECTIVES.
    Palmeira-de-Oliveira R; Macedo M; Machado RM; Pacheco AF; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Duarte P
    Int J Pharm Compd; 2016; 20(2):114-22. PubMed ID: 27323423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of compounding in independent community pharmacy practice.
    McPherson TB; Fontane PE; Jackson KD; Martin KS; Berry T; Chereson R; Bilger R
    J Am Pharm Assoc (2003); 2006; 46(5):568-73. PubMed ID: 17036642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purr-fecting skills: Design of a piloted veterinary pharmacy elective course with a compounding focus.
    Fredrickson ME; Parry V
    Curr Pharm Teach Learn; 2022 Aug; 14(8):1040-1045. PubMed ID: 36055694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential risks of pharmacy compounding.
    Gudeman J; Jozwiakowski M; Chollet J; Randell M
    Drugs R D; 2013 Mar; 13(1):1-8. PubMed ID: 23526368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specialty compounding for improved patient care: 2006 national survey of compounding pharmacists.
    Huffman DC; Holmes ER
    Int J Pharm Compd; 2008; 12(1):74-82. PubMed ID: 23969574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.
    Hines LE; Saverno KR; Warholak TL; Taylor A; Grizzle AJ; Murphy JE; Malone DC
    Res Social Adm Pharm; 2011 Dec; 7(4):359-68. PubMed ID: 21530417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.